4DMedical Limited (FDMDF)

OTCMKTS · Delayed Price · Currency is USD
0.2279
-0.1121 (-32.97%)
At close: Apr 16, 2025
-48.81%
Market Cap 85.63M
Revenue (ttm) 3.62M
Net Income (ttm) -24.47M
Shares Out n/a
EPS (ttm) -0.06
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 100
Average Volume 12,732
Open 0.2279
Previous Close 0.3400
Day's Range 0.2279 - 0.2279
52-Week Range 0.3204 - 0.4452
Beta 1.36
RSI 26.40
Earnings Date May 28, 2025

About 4DMedical

4DMedical Limited operates as a medical technology company in the United States and Australia. It engages in the medical research technology and development of a non‑invasive respiratory imaging solution using four‑dimensional imaging. The company also offers X-ray velocimetry lung ventilation analysis software (XV LVAS), a lung airflow imaging software, that provides lung health detail from X-Ray scans; computed tomography lung ventilation analysis software (CT LVAS), an image processing software which operates on CT scans to provide functiona... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2012
Employees 145
Stock Exchange OTCMKTS
Ticker Symbol FDMDF
Full Company Profile

Financial Performance

In 2024, 4DMedical's revenue was 3.75 million, an increase of 422.45% compared to the previous year's 718,581. Losses were -35.98 million, 14.4% more than in 2023.

Financial numbers in AUD Financial Statements

News

There is no news available yet.